We serve Chemical Name:cis-9-tetradecenyl acetate CAS:16725-53-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:cis-9-tetradecenyl acetate
CAS.NO:16725-53-4
Synonyms:cis-9-Tetradecenyl acetate;EINECS 240-780-1;9-tetradecenyl Acetate
Molecular Formula:C16H30O2
Molecular Weight:254.40800
HS Code:2915390090
Physical and Chemical Properties:
Melting point:41987ºC
Boiling point:135ºC(0.5 mmHg)
Density:0.878 g/cm3
Index of Refraction:1.4455-1.4475
PSA:26.30000
Exact Mass:254.22500
LogP:5.02660
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like cis-9-Tetradecenyl acetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,9-tetradecenyl Acetate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,cis-9-Tetradecenyl acetate Use and application,9-tetradecenyl Acetate technical grade,usp/ep/jp grade.
Related News: The ban will be in place for up to 14 days, and is aimed at helping contain the spread of the Wuhan coronavirus. So far, there have been no confirmed coronavirus cases in New Zealand or any South Pacific island. cis-9-tetradecenyl acetate manufacturer Today, Novavax is one step closer to addressing the critical and persistent global public health need for additional COVID-19 vaccines,” Novavax president and CEO Stanley Erck said in a statement. “These clinical results reinforce that [the vaccine] is extremely effective and offers complete protection against both moderate and severe COVID-19 infection. cis-9-tetradecenyl acetate supplier No amount of unmet need can take the place of sufficient evidence, said Johns Hopkins public health professor Dr. Caleb Alexander, a member of the FDA advisory panel. cis-9-tetradecenyl acetate vendor The drug substance is an active product that has completed the synthetic route, and the intermediate is a product in one place in the synthetic route. cis-9-tetradecenyl acetate factory In approving the first new Alzheimer’s drug in nearly 20 years, the U.S. Food and Drug Administration is taking its biggest risk yet with a strategy that allows new therapies onto the market without strong evidence that they work, regulatory and scientific experts say.
